| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |